INOZYME PHARMA INC

CUSIP: 45790W108 Class: Common Stock

BRIDGEWAY CAPITAL MANAGEMENT, LLC's Holding History (CIK: 0001107261)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 105,800 Value ($000) $96 Avg Close — Range —
Q4 2024
Shares 76,200 Value ($000) $211 Avg Close — Range —
Q3 2024
Shares 78,400 Value ($000) $410 Avg Close — Range —
Q1 2024
Shares 17,800 Value ($000) $136 Avg Close — Range —
Q4 2023
Shares 51,800 Value ($000) $221 Avg Close — Range —
Q3 2023
Shares 91,683 Value ($000) $385 Avg Close — Range —
Q2 2023
Shares 116,600 Value ($000) $649 Avg Close — Range —
Q1 2023
Shares 117,400 Value ($000) $673 Avg Close — Range —
Q4 2022
Shares 133,400 Value ($000) $140 Avg Close — Range —
Q3 2022
Shares 133,400 Value ($000) $358 Avg Close — Range —
Q2 2022
Shares 87,400 Value ($000) $417 Avg Close — Range —
Q1 2022
Shares 57,400 Value ($000) $235 Avg Close — Range —
Q4 2021
Shares 77,400 Value ($000) $528 Avg Close — Range —